AstraZeneca researchers show that automated microscale chromatography can generate process-characterization insights comparable to traditional bench-scale systems, potentially giving bioprocess developers a faster, material-sparing route to robust manufacturing control strategies for complex biologics. The post Microscale Chromatography Moves Toward Manufacturing Readiness appeared first on GEN -…
Single-use systems (SUS) bioprocessing technology has become mainstream. But the more interesting question today is what the industry needs next, and how SUS will enable the future. The post Single-Use Comes of Age–What Comes Next? appeared first on GEN - Genetic Engineering and Biotechnology News .
Thermo Fisher Scientific has opened a flagship U.S. Bioprocess Design Center (BDC) at its Plainville, Massachusetts, site, adding 4,000 square feet of lab and training space for biologics process development. The center gives biotech and pharma customers hands-on access to Thermo Fisher’s integrated bioproduction workflow, ranging from media to cell line development to chromatography and … The po…
Bioprocessing professionals are re-evaluating manufacturing models as product complexity increases and flexibility becomes critical. This article explores how modular facility design, single-use technologies, hybrid workflows, and digital automation help organizations evolve manufacturing operations to support scalable, adaptable bioproduction across development and commercial stages.
Introductio…
In the fast-paced world of bioprocessing, innovation and efficiency are key to staying ahead of the competition. For growing biotech companies and startups, the ability to quickly optimize processes and bring products to market can make the difference between success and failure. One vital strategy for achieving these goals is starting small with benchtop bioreactors. The post Start Small to Move…
